Market Analysis
New medicines in development for diseases that affect Hispanic Americans
Published in AIDS Weekly, October 16th, 2006
"America's pharmaceutical research companies are actively working to find treatments and cures for the more than 42.7 million Hispanic Americans, the largest minority group in the United States," said PhRMA President & CEO Billy Tauzin. "Studies show Hispanic Americans have an increased risk for certain conditions and often lack access to healthcare. PhRMA member companies are helping to solve these problems through the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-10-16)
More Articles from AIDS Weekly
- HIV/AIDS HAART
Rapid HAART scale-up at primary care sites in Zambia is feasible - HIV/AIDS HAART
Simplified maintenance therapy with atazanavir-ritonavir maintains virologic suppression - HIV/AIDS HAART
Time to virologic failure similar in HIV/AIDS patients taking 3- versus 4-drug regimens - HIV/AIDS Opportunistic Infection
Risk factors for opportunistic infections in HIV-infected children on HAART identified - HIV/AIDS Pathogenesis
Differential HIV-1 replication influenced at the level of viral gene expression - Acute Diarrheal Illness
Enteroaggregative Escherichia coli is a cause of acute diarrheal illness - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
